News

A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers. 

High-need, high-care patients taking part in focus group discussions arranged by Weill Cornell Medicine researchers have identified steps for reducing overuse of emergency departments and other hospital services to deliver effective care in less expensive ways.

How a patient and her doctor used precision medicine to fight her deadly uterine cancer.

Weill Cornell Medicine-Qatar added 49 new doctors—12 of whom are Qatari—to the medical profession during commencement on May 8.

A gene that originally evolved to help vertebrates’ early ancestors respond to stress is co-opted by cancers to help them resist treatment, according to a study by Weill Cornell Medicine investigators.

Trained in TB research, Pakistani native Dr. Omar Vandal, Ph.D. ’07, now oversees Gates Foundation grants that save lives worldwide.

A molecule that helps prevent fat accumulation in mammals is produced within fat tissues by stem-like cells that may be therapeutic targets for obesity and related disorders.

The work of global oncologists – whose insights and innovations reduce the burden of cancer around the world – has demonstrated value that academic medical leadership should consider when assessing these physicians for professional advancement, according to a commentary by Weill Cornell Medicine investigators.

After decades in pharmaceutical research, Dr. Bruce Reidenberg ’81, MD ’85, has found great satisfaction treating the developmentally disabled.

Awards, honors, prizes and achievements for the month of April.

Dr. Geraldine McGinty, chief strategy officer of Weill Cornell Medicine’s Physician Organization, has been named the 2019 recipient of the Jessica M. and Natan Bibliowicz Award for Excellence in Mentoring Women Faculty. 

Weill Cornell Medicine honored 17 faculty, trainees, students and staff April 22 for their outstanding service and leadership in promoting diversity at the academic medical institution.

Weill Cornell Medicine has experienced dynamic growth in its research enterprise over the past five years, an achievement that underscores the institution’s mission to provide patients with the most advanced treatments and therapies.

Weill Cornell Medicine kicks off its second annual Diversity Week on April 22, celebrating the varied backgrounds and perspectives that enrich the institution’s community.

Dr. Lisa Roth, assistant professor of pediatrics at Weill Cornell Medicine, and Dr. Bethany Cummings, assistant professor of biomedical sciences at the College of Veterinary Medicine, have each won a 2018 Hartwell Individual Biomedical Research Award, which will provide support for three years at $100,000 direct cost per year and designation as a Hartwell Investigator.

Neurologist Dr. Rebecca Gilbert serves as chief scientific Officer for the American Parkinson Disease Association

Weill Cornell Medicine researchers have shown that giving mice with triple-negative breast cancer therapeutic microRNA (miRNA) in a protective gold nanoparticle results in significantly less spreading of cancer to the lung.

The powerful but temporary benefits of ketamine against depression might be extended if the new brain-cell connections it promotes could be preserved, according to a new study.

Long-term spaceflight causes more changes to gene expression than shorter trips, especially to the immune system and DNA repair systems, according to research by Weill Cornell Medicine and NASA investigators as part of NASA’s Twins Study, which followed the only set of identical twin astronauts for more than two years.  

Neuroscientist Dr. Lisa Mosconi explores why women have a much higher risk of Alzheimer’s disease than men.